Harnessing AI to Design Antibodies Against Complex Targets in Autoimmune Diseases and Oncology

Biolojic Design uses proprietary computer-guided techniques to design novel antibodies against complex therapeutic targets.

Using 3D computer modeling, Biolojic is able to characterize binding sites with a very high degree of precision and then make amino acid level changes to known antibodies to dramatically improve their functionality and precision.

Biolojic's technology develops new, previously impossible potential for the power and capabilities of antibody technology to unlock the full potential of well-studied biological pathways.

Investing partner / fund: